Media Hits

Duke researcher Amy Gladfelter studies fungal cells to uncover clues about everything from disease and pregnancy to how organisms adapt to stress

Amanda Randles's HARVEY platform leverages supercomputing, physics-based simulations,and wearable device data to monitor real-time hemodynamics and spot heart failure early.

Sharon Gerecht's laboratory has constructed an in vitro model to study the inner blood–retina barrier.

Tatiana Segura's lab has developed an injectable biomaterial that helps transform the cavity left behind after a stroke caused by a blood clot into an environment more supportive of repair.

BME Professor Charlie Gersbach is one of several researchers worldwide interviewed for an article on using CRISPR to influence gene expression by editing the epigenome with the goal of treating disease.

Sharon Gerecht and her laboratory have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.

Jessilyn Dunn weighs in on what it takes for data gathered by wearables like blood pressure to be actionable in clinical settings as apps begin connecting users to physicians.

Amy Gladfelter describes her work studying "extreme cells" that break many of the rules of biology and may hold clues to pregnancy complications, certain diseases, and even cancer.

Gladfelter, a Duke Health Distinguished Professor of Cell Biology and Biomedical Engineering, is a quantitative cell biologist interested in fundamental mechanisms of cell organization

There’s no appreciable difference in people’s number of daily steps before and after a time change, according to Fitbit data drawn from 1,157 people in four U.S. states.

From 3D printed braces used by the NFL to a gel that can help regrow bones, all kinds of innovations are coming out of a Duke incubator called the BRiDGE.

Learn about the journey from academic researcher to entrepreneur and what it takes to launch a successful spin-out company, from Ashutosh Chilkoti, a serial founder